|Videos|June 6, 2017

C. difficile Tends to Be Over-Diagnosed in Healthcare Facilities

Niaz Banaei, MD, discusses some reasons why healthcare-associated C. difficile tends to be over-diagnosed.

Niaz Banaei, MD, Associate Professor, Pathology, Stanford University, discusses some reasons why healthcare-associated C. difficile tends to be over-diagnosed.

Interview Transcript (slightly modified for readability)

“[Clostridium] difficile colonization is quite common in patients [who] are entering hospitals and patients [who] are [already] hospitalized. These patients are then exposed to a number of reasons to develop nosocomial diarrhea, such as: they get antibiotics, chemotherapy, radiation, laxatives, and medications that induce diarrhea.

Then we look for Clostridium difficile as a cause of diarrhea in these patients. If they test negative, that’s easy; we assume that they don’t have C. diff infection, but if they test positive, we diagnose them as C. diff infection. In reality, a fraction of these patients are diagnosed with colonization, but given the diagnosis of infection. Almost all of these patients end up getting treated for C. diff infection, and, therefore, we are over diagnosing C. diff in a fraction of these patients.”


Related to this article

Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
IDSA/ESCMID Statement on Staphylococcus aureus: Follow-Up Blood Cultures
Staphylococcus aureus Bacteremia (SAB) causes significant morbidity and globally is the leading cause of death from bloodstream infection. This month, the IDSA and ESCMID released 7 consensus statements to assist in managing individuals with SAB. This review will focus on the adult patient population and additional information on pediatric population statements can be assessed in the guideline. Here is a closer look at Consensus Statement 2: Follow-up Blood Cultures.
Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
A new study in infants challenges the long-standing belief about the pathogen’s effects in the youngest pediatric population. Senior author Joseph Zackular, PhD, provides insights around his work including how it reshapes gut development and offers potential intervention strategies to shield neonates.